BioPharm International
December 01, 2013
From the Editor
26
12
Higher wages and employment rates give biopharm professionals an edge over counterparts in other industries.
December 01, 2013
Perspectives in Outsourcing
26
12
Ongoing changes create new opportunities for CROs and CMOs.
December 01, 2013
Features
26
12
A prototype Protein A resin is evaluated for purification performance, reusability, and cost performance.
December 01, 2013
European Beat
26
12
The European Union is strengthening its pioneering role in the regulation of biosimilars by further developing the basic rules for determining the levels of compatibility for this group of drugs. There are, however, some key issues that are not easy to resolve, as evident in a recent workshop on biosimilars organized by the European Medicines Agency (EMA).
December 01, 2013
Analytical Best Practices
26
12
Variation understanding and modeling is a core component of modern drug development.
December 01, 2013
Regulatory Beat
26
12
New policies and products seek to maintain access to pain medicines while curbing rampant abuse.
December 01, 2013
Features
26
12
Wolfgang Weikmann of Vetter Pharma discusses the implementation of quality by design in sterile manufacturing.
December 01, 2013
Features
26
12
Israel's diverse population, high-quality healthcare system, and resilience to global financial stress make it a strong partner for R'D, clinical research, and market growth.
December 01, 2013
Peer-Reviewed Research
26
12
Criticality is used as a risk-based tool to drive control strategies.
December 01, 2013
Cover Story
26
12
The employment picture brightened a bit, but biopharma employees still seek better compensation.
December 01, 2013
Global News
26
12
The rising cost of drug development and the decreasing proportion of drug-naive population in the US and European markets are driving international pharmaceutical companies to consider emerging markets as a location to conduct their clinical trials. Asia stands out among the emerging markets given its double-digit growth rates.
December 01, 2013
Issue PDF
26
12
Click the title above to open the BioPharm International December 2013 issue in an interactive PDF format.